āļāļēāļĢāļ§āļīāļāļąāļĒāđāļāļīāļāļĨāļķāļāđāļĨāļ°āļāļđāđāļĄāļ·āļāļāļđāđāđāļāļĩāđāļĒāļ§āļāļēāļāđāļāļĩāđāļĒāļ§āļāļąāļāļāļēāļĢāļĢāļąāļāļĐāļēāļŠāļļāļāļ āļēāļāļŠāļēāļĒāļāļēāļāļāļāļāļļāļ
Introduction Glaucoma affects tens of millions worldwide and is the second leading cause of irreversible blindness after cataract (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Most cases progress silently, and roughly 3% of adults over 40 have glaucoma â the majority undiagnosed (pmc.ncbi.nlm.nih.gov). Visual loss from glaucoma heavily degrades quality of life and raises lifetime costs; one s...
āđāļĢāļīāđāļĄāļāļēāļĢāļāļāļŠāļāļāļĨāļēāļāļŠāļēāļĒāļāļēāļāļĢāļĩāļāļāļāļāļļāļāđāļāđāļ§āļĨāļēāļāđāļāļĒāļāļ§āđāļē 5 āļāļēāļāļĩ
āđāļĢāļīāđāļĄāļāļāļŠāļāļāļāļąāļāļāļĩHow well a person follows their prescribed eye treatments, like using drops on schedule or attending appointments. Good adherence matters because skipping treatments can let eye diseases progress and worsen vision.
ðĨāļāļāļāļ§āļēāļĄāļĒāļāļ
